Use of Curcumin in Psoriasis
DOI:
https://doi.org/10.3889/oamjms.2018.055Keywords:
Psoriasis, Curcumin, Anti-inflammatory, Anti - oxidant, Efficacy, Safe profileAbstract
Curcumin is a polyphenol derived from the golden spice turmeric, which is widely used for different purposes, such as culinary spice and alimentary addictive, make - up and, finally, as a natural product for the treatment of different diseases, especially for the chronic inflammatory ones. Recently, curcumin has been proposed as a valid and safe therapeutic option for psoriasis.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Garodia P, Ichikawa H, Malani N, et Al. From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol. 2007; 5: 25–37. https://doi.org/10.2310/7200.2006.029 PMid:17309811
Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Medica. 1991; 57(1):1–7. https://doi.org/10.1055/s-2006-960004 PMid:2062949
Gupta SC, Patchva S, Koh W, et Al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012; 39 (3): 283–99. https://doi.org/10.1111/j.1440-1681.2011.05648.x PMid:22118895 PMCid:PMC3288651
Oppenheimer A. Turmeric (curcumin) in biliary diseases. Lancet. 1937; 229: 619–21. https://doi.org/10.1016/S0140-6736(00)98193-5
Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of curcumin: a short review. Life Sci. 2006; 78: 2081–2087. https://doi.org/10.1016/j.lfs.2005.12.007 PMid:16413584
Kim EJ, Lewis DJ, Dabaja BS et Al. Curcumin for the treatment of tumor - stage mycosis fungoides. Dermatol Ther. 2017; 30(4). https://doi.org/10.1111/dth.12511
Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto, ON: Churchill Livingstone, 2000.
Dixit VP, Jain P, Joshi SC. Hypolipidaemic effects of Curcuma longa L. and Nardostachys jatamansi, DC in triton-induced hyperlipidaemic rats. Indian J Physiol Pharmacol. 1988; 32: 299–304. PMid:3215683
Bundy R, Walker AF, Middleton RW, et al. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study. J Altern Complement Med. 2004; 10: 1015–8. https://doi.org/10.1089/acm.2004.10.1015 PMid:15673996
Hanai H, Sugimoto K. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des. 2009; 15: 2087–94. https://doi.org/10.2174/138161209788489177 PMid:19519446
Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4: 807–18. https://doi.org/10.1021/mp700113r PMid:17999464
Lotti T, Hercogova J, Prignano F. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities? Dermatol Ther. 2010; 23(2): 119-22. https://doi.org/10.1111/j.1529-8019.2010.01305.x PMid:20415818
Goren A, Salafia A, McCoy J et al. Novel topical cream delivers safe and effective alternative to traditional psoriasis phototherapy. Dermatol Ther. 2014; 27(5):260-3. https://doi.org/10.1111/dth.12132 PMid:24773915
Lotti T, Hercogova J. Successful treatment of psoriasis with low-dose per os interleukins 4, 10, and 11. Dermatol Ther. 2015; 28(1):1-2. https://doi.org/10.1111/dth.12174 PMid:25286191
Lotti T. Something new under the sun in the field of psoriasis? Dermatol Ther. 2010; 23(2):99-100. https://doi.org/10.1111/j.1529-8019.2010.01302.x PMid:20415815
Farahnik B, Nakamura M, Singh RK et Al. The Patient's Guide to Psoriasis Treatment. Part 2: PUVA Phototherapy. Dermatol Ther (Heidelb). 2016; 6(3):315-24. https://doi.org/10.1007/s13555-016-0130-9 PMid:27474030 PMCid:PMC4972736
Fioranelli M, Roccia MG, Lotti T. Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis. Dermatol Ther. 2017; 30(5). https://doi.org/10.1111/dth.12507
Barygina V., Becatti M, Soldi G, et Al. Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep. 2013; 18(3):100-6. https://doi.org/10.1179/1351000213Y.0000000045 PMid:23601139
Reddy S, Aggarwal BB. Curcumin is a non - ompetitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 1994; 341(1):19–22. https://doi.org/10.1016/0014-5793(94)80232-7
Heng MC, Song MK, Harker J, et al. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol. 2000; 143 (5): 937–49. https://doi.org/10.1046/j.1365-2133.2000.03767.x PMid:11069500
Varma SR, Sivaprakasam TO, Mishra A, et Al. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. Eyr J Pharmacol. 2017; 813: 33-41. https://doi.org/10.1016/j.ejphar.2017.07.040 PMid:28736282
Kang D, Luo L, Jiang W, et Al. Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie. 2016; 123: 73-80. https://doi.org/10.1016/j.biochi.2016.01.013 PMid:26826458
Kurd SK, Smith N, VanVoorhees A, Troxel AB, Badmaev V, Seykora JT, et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J A Acad Dermatol. 2008; 58(4):625–31. https://doi.org/10.1016/j.jaad.2007.12.035 PMid:18249471 PMCid:PMC4131208
Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Newton, MA: Integr Med Comm, 2000: 379–84.
Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, ulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009; 41(1):40–59. https://doi.org/10.1016/j.biocel.2008.06.010 PMid:18662800 PMCid:PMC2637808
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
